JP6908264B2 - Ceramide-containing non-aqueous gel composition and cosmetics containing it - Google Patents
Ceramide-containing non-aqueous gel composition and cosmetics containing it Download PDFInfo
- Publication number
- JP6908264B2 JP6908264B2 JP2017091331A JP2017091331A JP6908264B2 JP 6908264 B2 JP6908264 B2 JP 6908264B2 JP 2017091331 A JP2017091331 A JP 2017091331A JP 2017091331 A JP2017091331 A JP 2017091331A JP 6908264 B2 JP6908264 B2 JP 6908264B2
- Authority
- JP
- Japan
- Prior art keywords
- ceramide
- phase
- oil
- meadowfoam
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 57
- 229940106189 ceramide Drugs 0.000 title claims description 44
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 title claims description 40
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 title claims description 40
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 title claims description 40
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 title claims description 40
- 239000002537 cosmetic Substances 0.000 title claims description 24
- 241001072282 Limnanthes Species 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000013543 active substance Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 239000004973 liquid crystal related substance Substances 0.000 claims description 11
- 239000003921 oil Substances 0.000 description 40
- 235000019198 oils Nutrition 0.000 description 40
- 239000013078 crystal Substances 0.000 description 32
- 229940099417 ceramide 2 Drugs 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 12
- 229940057995 liquid paraffin Drugs 0.000 description 12
- 239000003205 fragrance Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 7
- -1 fatty acid ester Chemical class 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 6
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000001000 micrograph Methods 0.000 description 5
- 239000010466 nut oil Substances 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 4
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
- 238000002441 X-ray diffraction Methods 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 229940044176 ceramide 3 Drugs 0.000 description 4
- 150000001783 ceramides Chemical class 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 4
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 235000019488 nut oil Nutrition 0.000 description 4
- 229940031439 squalene Drugs 0.000 description 4
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 3
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 3
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 2
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 241000272185 Falco Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 229940060384 isostearyl isostearate Drugs 0.000 description 2
- 229940113915 isostearyl palmitate Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- PHLASVAENYNAOW-UHFFFAOYSA-N methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C)(C=1C=CC=CC=1)O[Si](C=1C=CC=CC=1)(C)O[Si](C)(C=1C=CC=CC=1)C1=CC=CC=C1 PHLASVAENYNAOW-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 229920001083 polybutene Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229940117985 trimethyl pentaphenyl trisiloxane Drugs 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- GNCPKADLMMNMND-VWLOTQADSA-N (2s)-2-[di(dodecanoyl)amino]pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N([C@@H](CCC(O)=O)C(O)=O)C(=O)CCCCCCCCCCC GNCPKADLMMNMND-VWLOTQADSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- QOOJEEZYYXGPAO-UHFFFAOYSA-N 2,2-bis(2-ethylhexanoyloxymethyl)butyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(CC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC QOOJEEZYYXGPAO-UHFFFAOYSA-N 0.000 description 1
- ILISIQVYOKYBLI-UHFFFAOYSA-N 2,3-di(hexadecanoyloxy)propyl 18,19-dihydroxynonadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC(O)CO ILISIQVYOKYBLI-UHFFFAOYSA-N 0.000 description 1
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3MC7 Natural products CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QCDJXLSJVLOQDQ-UHFFFAOYSA-N 7-methyl-1-(7-methyloctoxy)octane Chemical compound CC(C)CCCCCCOCCCCCCC(C)C QCDJXLSJVLOQDQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PKVYKIKWKPWIMO-UHFFFAOYSA-N bis(2-butyloctyl) decanedioate Chemical compound CCCCCCC(CCCC)COC(=O)CCCCCCCCC(=O)OCC(CCCC)CCCCCC PKVYKIKWKPWIMO-UHFFFAOYSA-N 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000010464 refined olive oil Substances 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 238000001988 small-angle X-ray diffraction Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- DUHIKWRPAQIIBL-UHFFFAOYSA-N tris(2-ethylhexyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCC(CC)COC(=O)CC(O)(C(=O)OCC(CC)CCCC)CC(=O)OCC(CC)CCCC DUHIKWRPAQIIBL-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000004736 wide-angle X-ray diffraction Methods 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Description
本発明は、セラミド含有非水ゲル状組成物及び該非水ゲル状組成物を含みかつ水を含まない化粧料に関する。 The present invention relates to a ceramide-containing non-water gel-like composition and a cosmetic containing the non-water gel-like composition and containing no water.
セラミドは皮膚の角層の細胞間脂質に含有され、皮膚バリア機能に寄与しているといわれており、高機能性保湿剤として注目されている。しかしながら、セラミドは一般に水溶性、油溶性を問わず化粧品基材への溶解性が悪いため、化粧料に多量に含有することが困難である。また、たとえ含有させることができても、経時的に結晶が析出し、化粧料の使用性や外観を損ない商品価値を下げてしまうという問題があった。 Ceramide is contained in the intercellular lipids of the stratum corneum of the skin and is said to contribute to the skin barrier function, and is attracting attention as a highly functional moisturizer. However, since ceramide generally has poor solubility in a cosmetic base material regardless of whether it is water-soluble or oil-soluble, it is difficult to contain it in a large amount in cosmetics. Further, even if it can be contained, there is a problem that crystals are precipitated with time, which impairs the usability and appearance of the cosmetic and lowers the commercial value.
セラミドは光学活性を持たないラセミ体と光学活性を持つ光学活性体とに分けられる。天然に存在するセラミドはすべて光学活性体であり、光学活性体の方が保湿効果が高いとされている。しかし一方で、光学活性体は融点が高く結晶性が強いため、化粧料に多量に含有させることは困難である(非特許文献1)。 Ceramides are divided into racemates that do not have optical activity and optically active substances that have optical activity. All naturally occurring ceramides are optically active substances, and it is said that the optically active substances have a higher moisturizing effect. However, on the other hand, since the optically active substance has a high melting point and strong crystallinity, it is difficult to include it in a large amount in cosmetics (Non-Patent Document 1).
セラミドを化粧料などの皮膚外用剤中に含有させるために、種々の化合物を組み合わせてその溶解性を向上させたり、結晶化を抑制する試みが数多く試されている。その中でも近年注目されているのは、肌の細胞間脂質を模した液晶構造を持つ組成物に関する技術である。液晶構造を持たせることによって、セラミドの肌への吸収性に優れる、水分蒸散抑制効果に優れる、使用性に優れるといった特徴を持つセラミド含有組成物ができる。 In order to contain ceramide in external preparations for skin such as cosmetics, many attempts have been made to combine various compounds to improve their solubility and suppress crystallization. Among them, the technology related to the composition having a liquid crystal structure imitating the intercellular lipids of the skin has been attracting attention in recent years. By having the liquid crystal structure, a ceramide-containing composition having characteristics such as excellent absorption of ceramide into the skin, excellent effect of suppressing water evaporation, and excellent usability can be obtained.
例えば、セラミド、脂肪族アルコール、及びポリグリセリン脂肪酸エステルを多価アルコール含有水性溶媒で分散させることにより、液晶構造を有した分散物が得られること、またこの技術によって使用性、安定性ともに優れた皮膚外用剤ができることが報告されている(特許文献1、特許文献2)。その他には、セラミド、高級脂肪酸又は高級アルコール、液体の非極性油又はシリコーン油、両親媒性高分子、水を含有する乳化化粧料は液晶構造を持ち、べたつきがなく使用性に優れ、水分蒸散抑制効果が高いと報告されている(特許文献3)。また他には、スフィンゴシン、セラミド、グリセリンモノ脂肪酸エステル、高級アルコール、水を含有する乳化組成物が報告されている(特許文献4)。これらの技術によって、結晶の析出が抑制されるとともに、経時安定性に優れ保湿効果の高い乳化組成物ができる。 For example, by dispersing ceramide, fatty alcohol, and polyglycerin fatty acid ester with a polyhydric alcohol-containing aqueous solvent, a dispersion having a liquid crystal structure can be obtained, and this technique is excellent in both usability and stability. It has been reported that an external preparation for skin can be produced (Patent Document 1, Patent Document 2). In addition, emulsified cosmetics containing ceramide, higher fatty acid or higher alcohol, liquid non-polar oil or silicone oil, amphipathic polymer, and water have a liquid crystal structure, are not sticky, are excellent in usability, and evaporate water. It has been reported that the inhibitory effect is high (Patent Document 3). In addition, an emulsified composition containing sphingosine, ceramide, glycerin monofatty acid ester, higher alcohol, and water has been reported (Patent Document 4). By these techniques, the precipitation of crystals is suppressed, and an emulsified composition having excellent stability over time and a high moisturizing effect can be produced.
しかし、これらの技術を持ってしても、セラミドの含有量には上限があり、高温、低温、冷凍融解等の各種経時安定性が不十分であるなど、産業上解決しなければならない課題が依然としてあり、その解決が望まれていた。 However, even with these technologies, there is an upper limit to the ceramide content, and there are problems that must be solved industrially, such as insufficient stability over time such as high temperature, low temperature, and freezing and thawing. It was still there, and a solution was desired.
本発明の目的は、セラミドを高含有しても油中で結晶化しない経時安定性に優れた非水ゲル状組成物、及び該非水ゲル状組成物を含有し、セラミドが結晶化せず経時安定性に優れた水を含まない化粧料を提供することである。 An object of the present invention is to contain a non-water gel-like composition having excellent stability over time that does not crystallize in oil even if it contains a high amount of ceramide, and the non-water gel-like composition that does not crystallize ceramide over time. It is to provide a water-free cosmetic with excellent stability.
かかる実情に鑑み、本発明者は鋭意検討した結果、光学活性体であるセラミド、メドウフォームエストリド、メドウフォームエストリドを除く25℃で液状である油剤を含有する非水ゲル状組成物は結晶が析出せず経時安定性に優れること、及び該非水ゲル状組成物を含有し水を含まない化粧料においても、結晶が析出せず経時安定性に優れることを見出した。 In view of such circumstances, as a result of diligent studies by the present inventor, a non-aqueous gel composition containing an oil agent which is liquid at 25 ° C. excluding the optically active substances ceramide, meadowfoam estride, and meadowfoam estride is crystalline. It was found that the crystals do not precipitate and are excellent in stability over time, and that even in a cosmetic containing the non-water gel-like composition and not containing water, crystals do not precipitate and the stability over time is excellent.
すなわち本発明は、次の成分(A)〜(C)
(A)光学活性体であるセラミド
(B)メドウフォームエストリド
(C)メドウフォームエストリドを除く25℃で液状である油剤
を含有する非水ゲル状組成物を提供するものである。
That is, in the present invention, the following components (A) to (C)
(A) Provided is a non-aqueous gel composition containing an oil agent which is liquid at 25 ° C. excluding ceramide (B) meadowfoam estride (C) meadowfoam estride which is an optically active substance.
また、本発明は、成分(A)の含有量が20.0重量%以下で、成分(B)の含有量が成分(A)の0.2倍〜2.0倍である非水ゲル状組成物を提供するものである。 Further, the present invention is in the form of a non-aqueous gel in which the content of the component (A) is 20.0% by weight or less and the content of the component (B) is 0.2 to 2.0 times that of the component (A). It provides a composition.
また、本発明は、成分(C)のうち50.0重量%以上が非極性油である非水ゲル状組成物を提供するものである。 The present invention also provides a non-aqueous gel composition in which 50.0% by weight or more of the component (C) is a non-polar oil.
また、本発明は、非水ゲル状組成物がラメラ液晶構造を有することを特徴とする非水ゲル状組成物を提供するものである。 The present invention also provides a non-aqueous gel-like composition characterized in that the non-aqueous gel-like composition has a lamellar liquid crystal structure.
また、本発明は、上記非水ゲル状組成物を含有し、かつ水を含まない化粧料を提供するものである。 The present invention also provides a cosmetic containing the non-water gel composition and containing no water.
本発明によって、セラミドが結晶化せず経時安定性に優れた非水ゲル状組成物及び該非水ゲル状組成物を含む水を含まない化粧料を提供することができる。 INDUSTRIAL APPLICABILITY According to the present invention, it is possible to provide a non-water gel-like composition in which ceramide does not crystallize and is excellent in stability over time, and a water-free cosmetic containing the non-water gel-like composition.
以下、本発明について詳細に説明する。
前述の通り、セラミドには光学活性体、ラセミ体があるが、本発明では光学活性体を用いる。本発明に使用されるセラミドとは、スフィンゴシンのアミノ基に長鎖脂肪酸がアミド結合した化合物の総称である。化粧品原料として使用されるものでは、スフィンゴシンの構造及び長鎖脂肪酸の構造の違いによりセラミド1〜6が知られている。本発明の成分(A)光学活性体であるセラミドは何れのセラミドでも使用できるが、その中でも、セラミド2、セラミド3、セラミド6が好ましい。これらのセラミドを用いたとき、特に経時安定性に優れたセラミド含有非水ゲル状組成物を得ることができるためである。また、これらは必要に応じて1種又は2種以上を用いることができる。セラミド2としては、高砂香料工業よりCERAMIDE TIC−001 が上市されており、これを購入して使用することができる。セラミド3としては、エボニックよりCeramide III、Ceramide IIIBが上市されており、これらを購入して使用することができる。セラミド6としてはエボニックよりCeramide VIが上市されており、これを購入して使用することができる。
Hereinafter, the present invention will be described in detail.
As described above, ceramide includes an optically active substance and a racemic form, but in the present invention, the optically active substance is used. The ceramide used in the present invention is a general term for compounds in which a long-chain fatty acid is amide-bonded to the amino group of sphingosine. Among those used as raw materials for cosmetics, ceramides 1 to 6 are known due to differences in the structure of sphingosine and the structure of long-chain fatty acids. The ceramide which is the component (A) optically active substance of the present invention can be used in any ceramide, and among them, ceramide 2, ceramide 3, and ceramide 6 are preferable. This is because when these ceramides are used, a ceramide-containing non-aqueous gel composition having particularly excellent stability over time can be obtained. In addition, one kind or two or more kinds of these can be used as needed. As ceramide 2, CERAMIDE TIC-001 has been put on the market by Takasago International Corporation, and it can be purchased and used. As ceramide 3, Ceramide III and Ceramide IIIB have been marketed by Evonik, and these can be purchased and used. As ceramide 6, Ceramide VI has been put on the market by Evonik, and it can be purchased and used.
成分(A)光学活性体であるセラミドの含有量は特に限定されないが、非水ゲル状組成物全体の20.0重量%以下が好ましい。20.0重量%を超えると結晶が析出する場合がある。 The content of the ceramide which is the component (A) optically active substance is not particularly limited, but is preferably 20.0% by weight or less of the whole non-aqueous gel composition. If it exceeds 20.0% by weight, crystals may precipitate.
本発明の成分(B)メドウフォームエストリドはメドウフォーム油由来の脂肪酸とヒドロキシ脂肪酸を脱水縮合しエステル化した液状の極性油剤である。メドウフォームエストリドは、一丸ファルコスよりメドウエストリドが上市されており、これを購入して使用することができる。 The component (B) Meadowfoam Estride of the present invention is a liquid polar oil prepared by dehydrating and condensing a fatty acid derived from Meadowfoam oil and a hydroxy fatty acid and esterifying them. Meadowfoam Estrid is available on the market from Ichimaru Falcos, and you can purchase and use it.
成分(B)メドウフォームエストリドの含有量は特に限定されないが、成分(A)の含有量の0.2倍〜2.0倍であることが好ましい。0.2倍未満もしくは2.0倍を超えると、ゲル状組成物中に経時的にセラミドの結晶が析出してしまうという問題が生じる場合がある。 The content of the component (B) meadowfoam estride is not particularly limited, but is preferably 0.2 to 2.0 times the content of the component (A). If it is less than 0.2 times or more than 2.0 times, there may be a problem that ceramide crystals are precipitated in the gel-like composition over time.
本発明の成分(C)メドウフォームエストリドを除く25℃で液状である油剤としては、通常化粧料に用いられる非極性油、極性油、シリコーン油などの油剤が使用できる。非極性油とは炭素と水素のみからなる油剤であり、例としてはイソドデカン、イソヘキサデカン、軽質流動イソパラフィン、流動パラフィン、重質流動イソパラフィン、α−オレフィンオリゴマー、スクワラン、ポリイソブチレン、ポリブテン等が挙げられるがこれらに限定するものではない。極性油とは高級脂肪酸、高級アルコール、油脂、エーテル、エステル油等の分子中に水酸基、カルボキシル基、エーテル結合、エステル結合を含む油剤であり、例としてはオレイン酸、イソステアリン酸、リノール酸、オレイルアルコール、イソステアリルアルコール、アボカド油、オリーブ油、パーシック油、ククイナッツ油、ブドウ種子油、サフラワー油、アーモンド油、コーン油、ピスタシオ種子油、ヒマワリ油、ヘーゼルナッツ油、マカデミアナッツ油、メドウフォーム油、ローズヒップ油、ジイソノニルエーテル、ホホバ油、ミリスチン酸ブチル、ステアリン酸ブチル、エチルヘキサン酸セチル、オレイン酸エチル、イソステアリン酸ヘキシルデシル、ミリスチン酸イソセチル、ステアリン酸イソセチル、パルミチン酸エチルヘキシル、イソステアリン酸イソプロピル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸イソステアリル、ミリスチン酸オクチルドデシル、ステアリン酸エチルヘキシル、リノール酸エチル、リノール酸イソプロピル、ネオペンタン酸オクチルドデシル、サリチル酸ブチルオクチル、トリイソステアリン酸ジグリセリル、ジカプリン酸プロピレングリコール、テトラエチルヘキサン酸ペンタエリスリチル、モノカプリル酸プロピレングリコール、ジカプリル酸プロピレングリコール、トリエチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、トリ2−エチルヘキサン酸グリセリル、トリ(カプリル酸/カプリン酸)グリセリル、2−エチルヘキサン酸2−ブチル−2−エチル−1,3−プロパンジオール、セバシン酸ジエチル、アジピン酸ジイソプロピル、セバシン酸ジイソプロピル、2,6−ナフタリンジカルボン酸ジ2−エチルヘキシル、セバシン酸ジブチルオクチル、リンゴ酸ジイソステアリル、クエン酸トリエチルヘキシル、トリイソステアリン酸ジグリセリル、ペンタオレイン酸デカグリセリル、デカイソステアリン酸デカグリセリル、デカオレイン酸デカグリセリル、デカマカデミアナッツ油脂肪酸デカグリセリル等が挙げられるがこれらに限定されるものではない。シリコーン油とはケイ素と酸素がシロキサン結合により交互に連なった骨格を持つ油剤である。シリコーン油のうちメドウフォームエストリドと相溶性のあるシリコーン油であれば本発明に用いることができる。例としてはジメチルシリコーン、メチルフェニルシリコーン、環状ジメチルシリコーン、アルキル変性シリコーン等が挙げられるがこれらに限定されるものではない。また、これらは必要に応じて、1種又は2種以上を用いることができる。 As the oil agent liquid at 25 ° C. excluding the component (C) Meadowfoam Estride of the present invention, oil agents such as non-polar oil, polar oil, and silicone oil usually used in cosmetics can be used. Non-polar oils are oils consisting only of carbon and hydrogen, and examples thereof include isododecane, isohexadecane, light liquid isoparaffin, liquid paraffin, heavy liquid isoparaffin, α-olefin oligomer, squalane, polyisobutylene, polybutene and the like. Is not limited to these. Polar oil is an oil agent containing a hydroxyl group, a carboxyl group, an ether bond, and an ester bond in molecules such as higher fatty acids, higher alcohols, fats and oils, ethers, and ester oils, and examples thereof include oleic acid, isostearic acid, linoleic acid, and oleyl. Alcohol, isostearic alcohol, avocado oil, olive oil, persic oil, kukui nut oil, grape seed oil, saflower oil, almond oil, corn oil, pistacio seed oil, sunflower oil, hazelnut oil, macadamia nut oil, meadowfoam oil, rose hips Oil, diisononyl ether, jojoba oil, butyl myristate, butyl stearate, cetyl ethylhexanate, ethyl oleate, hexyldecyl isostearate, isosetyl myristate, isosetyl stearate, ethylhexyl palmitate, isopropyl isostearate, isopropyl myristate, Isostearyl palmitate, isostearyl palmitate, octyldodecyl myristate, ethylhexyl stearate, ethyl linoleate, isopropyl linoleate, octyldodecyl neopentate, butyloctyl salicylate, diglyceryl triisostearate, propylene glycol dicaprate, pentaethylhexanoate tetraethylhexanoate Elyslityl, propylene glycol monocaptrylate, propylene glycol dicaprylate, trimethylolpropane triethylhexanoate, trimethylolpropane triisostearate, glyceryl tri2-ethylhexanoate, glyceryl tri (caprylic acid / capric acid), 2-ethylhexane 2-Butyl-2-ethyl acid-1,3-propanediol, diethyl sebacate, diisopropyl adipate, diisopropyl sebacate, di2-ethylhexyl 2,6-naphthalindicarboxylate, dibutyloctyl sebacate, diisostearyl malate , Triethylhexyl citrate, diglyceryl triisostearate, decaglyceryl pentaoleate, decaglyceryl decaisostearate, decaglyceryl decaoleate, decaglyceryl decamacademia nut oil fatty acid, and the like, but are not limited thereto. Silicone oil is an oil agent having a skeleton in which silicon and oxygen are alternately connected by siloxane bonds. Of the silicone oils, any silicone oil compatible with Meadowfoam Estride can be used in the present invention. Examples include, but are not limited to, dimethyl silicone, methyl phenyl silicone, cyclic dimethyl silicone, alkyl-modified silicone and the like. Moreover, these may use 1 type or 2 or more types as needed.
本発明では特に、成分(C)のうち、50.0重量%以上が非極性油であることが好ましい。50.0重量%未満であると、経時的にセラミドの結晶が析出してしまう場合がある。 In the present invention, it is particularly preferable that 50.0% by weight or more of the component (C) is a non-polar oil. If it is less than 50.0% by weight, ceramide crystals may precipitate over time.
成分(A)、成分(B)、及び成分(C)を加温し溶解したことを確認した後、30℃まで冷却すると非水ゲル状組成物ができる。該非水ゲル状組成物は、ラメラ液晶構造を有し、長期間セラミドの結晶が析出せず、経時的に安定である。 After confirming that the component (A), the component (B), and the component (C) are heated and dissolved, the non-aqueous gel composition is formed by cooling to 30 ° C. The non-aqueous gel-like composition has a lamellar liquid crystal structure, ceramide crystals do not precipitate for a long period of time, and the composition is stable over time.
本発明のセラミド含有非水ゲル状組成物には、その使用目的に応じて各種成分、例えば、アニオン性界面活性剤、カチオン性界面活性剤、非イオン性界面活性剤、25℃で固形状あるいはペースト状である油剤、紫外線吸収剤、防腐剤、保湿剤、増粘剤、色剤、金属イオン封鎖剤、酸化防止剤、美容成分、香料、清涼剤、pH調整剤等を適宜含有することができる。しかし、これらの各種成分は合計で0.5重量%以下であることが好ましい。0.5重量%を超えると、経時的にセラミドの結晶が析出してしまう場合がある。 The ceramide-containing non-aqueous gel composition of the present invention contains various components, for example, anionic surfactant, cationic surfactant, nonionic surfactant, solid at 25 ° C. or It may contain paste-like oils, UV absorbers, preservatives, moisturizers, thickeners, coloring agents, sequestrants, antioxidants, beauty ingredients, fragrances, refreshing agents, pH adjusters, etc. as appropriate. can. However, these various components are preferably 0.5% by weight or less in total. If it exceeds 0.5% by weight, ceramide crystals may precipitate over time.
本発明では、上記のセラミド含有非水ゲル状組成物を水を含まない化粧料に含有させることによって、セラミドの結晶が析出せず経時安定性に優れた化粧料を提供できる。一方、水を含む化粧料に該非水ゲル状組成物を含有させるとセラミドの結晶が析出し、経時安定性に問題が生じる場合がある。 In the present invention, by incorporating the above-mentioned ceramide-containing non-aqueous gel-like composition into a water-free cosmetic, it is possible to provide a cosmetic having excellent stability over time without precipitation of ceramide crystals. On the other hand, when the non-water gel-like composition is contained in a cosmetic containing water, ceramide crystals may be precipitated, which may cause a problem in stability over time.
本発明のセラミド含有非水ゲル状組成物の融点は85℃付近であるので、該非水ゲル状組成物を含有する化粧料を調製する場合、該非水ゲル状組成物を融点より低い温度である例えば80℃以下で投入し、ロールミルや、ホモミキサー、ディスパーミキサーなどを使用し、分散すれば良い。 Since the melting point of the ceramide-containing non-aqueous gel composition of the present invention is around 85 ° C., when preparing a cosmetic containing the non-aqueous gel composition, the temperature of the non-aqueous gel composition is lower than the melting point. For example, it may be charged at 80 ° C. or lower and dispersed using a roll mill, a homomixer, a disper mixer or the like.
本発明のセラミド含有非水ゲル状組成物を含有する化粧料に含有させる該非水ゲル状組成物は化粧料全体の0.1重量%〜50.0重量%であることが望ましい。0.1重量%未満では、高含有という目的を達成し得ない場合があり、50.0重量%を超えると、求める使用感が得られなくなる場合がある。 It is desirable that the non-water gel composition to be contained in the cosmetic containing the ceramide-containing non-water gel composition of the present invention is 0.1% by weight to 50.0% by weight of the whole cosmetic. If it is less than 0.1% by weight, the purpose of high content may not be achieved, and if it exceeds 50.0% by weight, the desired usability may not be obtained.
本発明のセラミド含有非水ゲル状組成物を含む化粧料には、発明の効果を損なわない範囲で、その使用目的に応じて各種成分、例えば、アニオン性界面活性剤、カチオン性界面活性剤、非イオン性界面活性剤、油剤、紫外線吸収剤、防腐剤、保湿剤、増粘剤、色剤、金属イオン封鎖剤、酸化防止剤、美容成分、香料、清涼剤、pH調整剤等を適宜含有することができる。 The cosmetic containing the ceramide-containing non-aqueous gel composition of the present invention includes various components, for example, anionic surfactants and cationic surfactants, depending on the purpose of use, as long as the effects of the invention are not impaired. Appropriately contains nonionic surfactants, oils, UV absorbers, preservatives, moisturizers, thickeners, coloring agents, metal ion sequestering agents, antioxidants, beauty ingredients, fragrances, refreshing agents, pH adjusters, etc. can do.
本発明のセラミド含有非水ゲル状組成物は、これだけでもバーム状美容液やリップバームとして用いることができる。また、該非水ゲル状組成物を他の成分に分散させたセラミド含有非水ゲル状組成物を含む化粧料としては、オイル美容液、リップグロス、ボディオイル、ヘヤーオイル、ヘヤーワックス、アイグロス、油性ファンデーション、口紅オーバーコート、リップエッセンス、リキッドルージュなどを例示することができる。 The ceramide-containing non-aqueous gel composition of the present invention can be used alone as a balm-like beauty essence or lip balm. In addition, as cosmetics containing a ceramide-containing non-water gel-like composition in which the non-water gel-like composition is dispersed in other components, oil beauty liquid, lip gloss, body oil, hair oil, hair wax, eye gloss, and oiliness Examples include foundations, lipstick overcoats, lip essences, and liquid rouge.
以下、実施例を挙げて本発明をさらに詳細に説明するが、本発明はこれら実施例により何ら限定されるものではない。例中の含有量はすべて重量%である。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. The contents in the examples are all% by weight.
実施例1〜実施例25、比較例1〜比較例11 セラミド含有非水ゲル状組成物
セラミド、メドウフォームエストリド、及びメドウフォームエストリドを除く25℃で液状である油剤を含有する非水ゲル状組成物の調製方法及び評価法について詳細に説明する。以下に示す実施例1〜25及び比較例1〜11に示した処方にて、すべての成分を95℃まで加温し、処方中のペースト状または固形状成分が完全に溶解したことを確認した後、30℃まで冷却した。得られた組成物を40℃で1ヶ月間、3ヶ月間及び6ヶ月間放置した後の様子を偏光顕微鏡によってクロスニコル下で観察し、以下のように分類した。
<偏光顕微鏡像>
○:テクスチャーが見られ、結晶が見られない。
△:テクスチャーが見られるが、結晶も見られる。
×:テクスチャーが見られず、結晶が見られる。
−:テクスチャーも結晶も見られない。
尚、テクスチャーとは流動により分子の配向に急激な不均一性のある欠陥が生じた際に見られる模様で、液晶構造を有することを示唆するものである。また、図1は実施例3に見られたテクスチャーの様子、図2は比較例5に見られた結晶の様子を表す。分類した結果を表中に示した。
Examples 1 to 25, Comparative Examples 1 to 11 Ceramide-containing non-aqueous gel composition A non-aqueous gel containing an oil agent that is liquid at 25 ° C. excluding ceramide, meadowfoam estride, and meadowfoam estride. The preparation method and the evaluation method of the state composition will be described in detail. In the formulations shown in Examples 1 to 25 and Comparative Examples 1 to 11 shown below, all the components were heated to 95 ° C., and it was confirmed that the paste-like or solid components in the formulation were completely dissolved. After that, it was cooled to 30 ° C. The state of the obtained composition after being left at 40 ° C. for 1 month, 3 months and 6 months was observed with a polarizing microscope under a cross Nicol, and classified as follows.
<Polarizing microscope image>
◯: Texture is seen, and no crystals are seen.
Δ: Texture can be seen, but crystals can also be seen.
X: No texture is seen and crystals are seen.
-: No texture or crystals can be seen.
It should be noted that the texture is a pattern that is seen when a defect having a rapid non-uniformity in the orientation of the molecule is generated due to the flow, and suggests that it has a liquid crystal structure. Further, FIG. 1 shows the state of the texture seen in Example 3, and FIG. 2 shows the state of the crystal seen in Comparative Example 5. The classification results are shown in the table.
*2:メドウエストリド(一丸ファルコス製)
*3:CARNATION(SONNEBORN IMC製)
* 2: Medwest lid (made by Ichimaru Falcos)
* 3: CARANTION (manufactured by SONNEBORN IMC)
表1の実施例1〜7にセラミド2とメドウフォームエストリドの割合を固定しつつ、セラミド2の含有量を変化させた場合の結果を示す。実施例1〜6では40℃で1ヶ月間、3ヶ月間及び6ヶ月間放置した後も結晶が見られずテクスチャーのみが確認された。実施例7では40℃で1ヶ月間及び3ヶ月間放置した後では結晶が見られずテクスチャーのみが確認されたが、40℃で6ヶ月間放置した後ではテクスチャーとともに結晶が確認された。 The results of changing the content of ceramide 2 while fixing the ratio of ceramide 2 and meadowfoam estride are shown in Examples 1 to 7 of Table 1. In Examples 1 to 6, no crystals were observed even after being left at 40 ° C. for 1 month, 3 months and 6 months, and only the texture was confirmed. In Example 7, no crystals were observed and only the texture was confirmed after being left at 40 ° C. for 1 month and 3 months, but after being left at 40 ° C. for 6 months, crystals were confirmed together with the texture.
*4:EXTRA OLEIC−90(日油製)
*5:オレイルアルコール VP(高級アルコール工業製)
*6:イソステアリン酸(日産化学工業製)
*7:ファインオキソコール 180(日産化学工業製)
*8:12−ヒドロキシステアリン酸(伊藤製油製)
*9:NAA−173K(日油製)
*10:ステアリルアルコール NX(高級アルコール工業製)
* 4: EXTRA OLEIC-90 (manufactured by NOF)
* 5: Oleyl alcohol VP (manufactured by higher alcohol industry)
* 6: Isostearic acid (manufactured by Nissan Chemical Industries, Ltd.)
* 7: Fine Oxyacid 180 (manufactured by Nissan Chemical Industries, Ltd.)
* 8: 12-Hydroxystearic acid (manufactured by Itoh Oil Chemicals)
* 9: NAA-173K (manufactured by NOF)
* 10: Stearyl alcohol NX (manufactured by higher alcohol industry)
表2の比較例1にメドウフォームエストリドを含有しない場合の結果、比較例2〜8にメドウフォームエストリドを含有せず、メドウフォームエストリドの代わりに比較的似た化学構造を持つ脂肪酸、あるいは高級アルコールを含有させた場合の結果を示す。比較例1〜8では40℃で1ヶ月間、3ヶ月間及び6ヶ月間放置した後、いずれの場合もテクスチャーは見られず、結晶のみが確認された。 As a result of the case where Comparative Example 1 in Table 2 does not contain Meadowfoam Estride, Fatty Acids which do not contain Meadowfoam Estride in Comparative Examples 2 to 8 and have a relatively similar chemical structure instead of Meadowfoam Estride. Alternatively, the result when a higher alcohol is contained is shown. In Comparative Examples 1 to 8, after being left at 40 ° C. for 1 month, 3 months and 6 months, no texture was observed in any of the cases, and only crystals were confirmed.
*11:パールリーム EX(日油製)
*12:NIKKOL シュガースクワラン(日光ケミカルズ製)
* 11: Pearl Dream EX (manufactured by NOF)
* 12: NIKKOL Sugar Squalene (manufactured by Nikko Chemicals)
表3の実施例8〜14にセラミド2の含有量を固定しつつ、メドウフォームエストリドの含有量を変化させた場合の結果を示す。実施例9〜13では40℃で1ヶ月間、3ヶ月間及び6ヶ月間放置した後も結晶が見られずテクスチャーのみが確認された。実施例8、14では40℃で1ヶ月間及び3ヶ月間放置した後では結晶が見られずテクスチャーのみが確認されたが、40℃で6ヶ月間放置した後ではテクスチャーとともに結晶が確認された。 The results when the content of meadowfoam estride was changed while fixing the content of ceramide 2 in Examples 8 to 14 of Table 3 are shown. In Examples 9 to 13, no crystals were observed even after being left at 40 ° C. for 1 month, 3 months and 6 months, and only the texture was confirmed. In Examples 8 and 14, no crystals were observed after being left at 40 ° C. for 1 month and 3 months, and only the texture was confirmed, but after being left at 40 ° C. for 6 months, crystals were confirmed together with the texture. ..
*13:NIKKOL シンセラン4SP(日光ケミカルズ製)
*14:ODM(高級アルコール工業製)
*15:Plandool−LG1(日本精化製)
* 13: NIKKOL Syntheran 4SP (manufactured by Nikko Chemicals)
* 14: ODM (manufactured by higher alcohol industry)
* 15: Plandoll-LG1 (manufactured by Nippon Fine Chemical Co., Ltd.)
表4の実施例15〜20にセラミド2、メドウフォームエストリド及びラウロイルグルタミン酸ジ(オクチルドデシル/フィトステリル/ベへニル)の含有量を固定しつつ、非極性油であるα−オレフィンオリゴマーと極性油であるミリスチン酸オクチルドデシルとの割合を変化させた場合の結果を示す。実施例15〜17では40℃で1ヶ月間、3ヶ月間及び6ヶ月間放置した後も結晶が見られずテクスチャーのみが確認された。実施例18〜20では40℃で1ヶ月間及び3ヶ月間放置した後では結晶が見られずテクスチャーのみが確認されたが、40℃で6ヶ月間放置した後ではテクスチャーとともに結晶が確認された。 Α-olefin oligomers and polar oils, which are non-polar oils, while fixing the contents of ceramide 2, meadowfoam estride and di (octyldodecyl / phytosteryl / behenyl) lauroyl glutamate in Examples 15 to 20 in Table 4. The results when the ratio with octyldodecyl myristate is changed are shown. In Examples 15 to 17, no crystals were observed even after being left at 40 ° C. for 1 month, 3 months and 6 months, and only the texture was confirmed. In Examples 18 to 20, no crystals were observed after being left at 40 ° C. for 1 month and 3 months, and only the texture was confirmed, but after being left at 40 ° C. for 6 months, crystals were confirmed together with the texture. ..
表5の比較例9〜11にメドウフォームエストリドを除く25℃で液状である油剤を含有しない場合の結果を示す。比較例9では40℃で1ヶ月間、3ヶ月間及び6ヶ月間放置した後で結晶もテクスチャーも確認されず外観もゲル状組成物とならなかった。比較例10、11では1ヶ月間、3ヶ月間及び6ヶ月間放置した後で結晶のみが確認された。 Comparative Examples 9 to 11 in Table 5 show the results when the oil agent which is liquid at 25 ° C. excluding Meadowfoam Estride is not contained. In Comparative Example 9, after being left at 40 ° C. for 1 month, 3 months and 6 months, neither crystals nor textures were confirmed, and the appearance did not become a gel-like composition. In Comparative Examples 10 and 11, only crystals were confirmed after being left for 1 month, 3 months and 6 months.
*16:フィトステロール−SKP(タマ生化学製)
*17:NIKKOL レシノール S−PIE(日光ケミカルズ製)
*18:メッキンス−B(上野製薬製)
* 16: Phytosterol-SKP (manufactured by Tama Biochemical)
* 17: NIKKOL Resinol S-PIE (manufactured by Nikko Chemicals)
* 18: Plating-B (manufactured by Ueno Fine Chemicals)
表6の実施例21〜26にセラミド2、メドウフォームエストリド、水添レシチン及びブチルパラベンの割合を固定しつつ、フィトステロールの含有量を変化させた場合の結果を示す。実施例21〜24では40℃で1ヶ月間、3ヶ月間及び6ヶ月間放置した後も結晶が見られずテクスチャーのみが確認された。実施例25及び実施例26では40℃で1ヶ月間及び3ヶ月間放置した後では結晶が見られずテクスチャーのみが確認されたが、40℃で6ヶ月間放置した後ではテクスチャーとともに結晶が確認された。
The results of changing the content of phytosterol while fixing the ratios of ceramide 2, meadowfoam estride, hydrogenated lecithin and butylparaben are shown in Examples 21 to 26 of Table 6. In Examples 21 to 24, no crystals were observed and only the texture was confirmed even after being left at 40 ° C. for 1 month, 3 months and 6 months. In Examples 25 and 26, no crystals were observed after being left at 40 ° C. for 1 month and 3 months, and only the texture was confirmed. However, after being left at 40 ° C. for 6 months, crystals were confirmed together with the texture. Was done.
本発明のセラミド含有非水ゲル状組成物の内部構造を確認するために、あいちシンクロトロン光センターのビームラインBL8S3において、小角・広角X線回折同時測定を行った。X線のエネルギー13.9KeV、X線の波長0.09nm、カメラ長468mm、照射時間300秒にて測定を行い、カメラにはRAXIS(リガク製)を用い、イメージングプレートは300×300mmを使用した。試料はアルミニウム製のDSCセル(メトラー製)に詰めて測定した。得られた回折像はFIT2D(ESRF)プログラムにて一次元化し、横軸を散乱ベクトルS(=q/2π)、縦軸を散乱強度としてプロットした。 In order to confirm the internal structure of the ceramide-containing non-aqueous gel composition of the present invention, simultaneous small-angle and wide-angle X-ray diffraction measurements were performed at the beamline BL8S3 of the Aichi Synchrotron Optical Center. The X-ray energy was 13.9 KeV, the X-ray wavelength was 0.09 nm, the camera length was 468 mm, and the irradiation time was 300 seconds. RAXIS (manufactured by Rigaku) was used for the camera, and 300 x 300 mm was used for the imaging plate. .. The sample was measured by packing it in an aluminum DSC cell (manufactured by METTLER). The obtained diffraction image was made one-dimensional by the FIT2D (ESRF) program, and the horizontal axis was plotted as the scattering vector S (= q / 2π) and the vertical axis was plotted as the scattering intensity.
図3に小角領域のX線回折プロファイル、図4に広角領域のX線回折プロファイルをそれぞれ示す。図3の実施例4においては、ラメラ構造の1次、2次及び3次の回折ピークがそれぞれ0.217nm−1(4.61nm)、0.432nm−1(2.31nm)及び0.655nm−1(1.53nm)に現れており、約4.6nmの周期を持つラメラ構造が存在することを示す。同様に、図3の比較例1においては、ラメラ構造の1次、2次及び3次の回折ピークがそれぞれ0.249nm−1(4.02nm)、0.502nm−1(1.99nm)及び0.750nm−1(1.33nm)に現れており、約4.0nmの周期を持つラメラ構造が存在することを示す。実施例4の方が面間隔が広くなっているのは、ラメラ構造内に油剤を抱え込んでいるためと推察される。また図4の実施例4においては、2.50nm−1(0.40nm)にブロードな回折ピークが見られる。これは充填構造に秩序性は乏しく液晶構造であることを示すものである。一方、比較例1においては、2.22nm−1(0.45nm)と2.66nm−1(0.38nm)とに2つ回折ピークが見られる。これは実施例4の充填構造とは明らかに異なり、斜方晶が存在することを意味している。つまり、実施例4は比較例1と異なり、ラメラ液晶構造を持っていることがわかる。 FIG. 3 shows an X-ray diffraction profile in a small angle region, and FIG. 4 shows an X-ray diffraction profile in a wide angle region. In Example 4 of FIG. 3, the primary, secondary and tertiary diffraction peaks of the lamellar structure are 0.217 nm -1 (4.61 nm), 0.432 nm -1 (2.31 nm) and 0.655 nm, respectively. It appears at -1 (1.53 nm), indicating the existence of a lamellar structure with a period of about 4.6 nm. Similarly, in Comparative Example 1 of FIG. 3, the primary, secondary and tertiary diffraction peaks of the lamellar structure are 0.249 nm -1 (4.02 nm), 0.502 nm -1 (1.99 nm) and 0.502 nm -1 (1.99 nm), respectively. It appears at 0.750 nm -1 (1.33 nm), indicating the presence of a lamellar structure with a period of about 4.0 nm. It is presumed that the reason why the surface spacing is wider in Example 4 is that the oil agent is held in the lamellar structure. Further, in Example 4 of FIG. 4, a broad diffraction peak is observed at 2.50 nm -1 (0.40 nm). This indicates that the packed structure is poorly ordered and has a liquid crystal structure. On the other hand, in Comparative Example 1, two diffraction peaks are observed at 2.22 nm -1 (0.45 nm) and 2.66 nm -1 (0.38 nm). This is clearly different from the packed structure of Example 4 and means that orthorhombic crystals are present. That is, it can be seen that Example 4 has a lamellar liquid crystal structure unlike Comparative Example 1.
以下に上記ゲル状組成物を含有しかつ水を含まない化粧料の実施例を挙げる。図5は実施例27の偏光顕微鏡像である。マルテーゼクロスが現れておりラメラ液晶構造を有するゲル状物が分散していることを示唆するものである。 Examples of cosmetics containing the gel-like composition and not containing water will be given below. FIG. 5 is a polarizing microscope image of Example 27. Martese cloth appears, suggesting that the gel-like substance having a lamellar liquid crystal structure is dispersed.
実施例27 リップグロス
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 2.0
(2) メドウフォームエストリド (*2) 3.0
(3) 流動パラフィン(*3) 10.0
(B相)
(4) パルミチン酸デキストリン 5.0
(5) 流動パラフィン 10.0
(6) リンゴ酸ジイソステアリル 10.0
(7) メチルフェニルポリシロキサン 10.0
(8) トリイソステアリン酸ジグリセリル 残量
(9) 香料 適量
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相を30℃で加え、ロールミルにて均一に混合分散する。
Example 27 Lip gloss (ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 2.0
(2) Meadowfoam Estride (* 2) 3.0
(3) Liquid paraffin (* 3) 10.0
(Phase B)
(4) Dextrin palmitate 5.0
(5) Liquid paraffin 10.0
(6) Diisostearyl malate 10.0
(7) Methylphenylpolysiloxane 10.0
(8) Diglyceryl triisostearate Remaining amount (9) Appropriate amount of fragrance (manufacturing method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. Phase A is added to phase B at 30 ° C., and the mixture is uniformly mixed and dispersed on a roll mill.
実施例28 リキッドルージュ
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 0.5
(2) メドウフォームエストリド(*2) 0.9
(3) 流動パラフィン(*3) 8.0
(B相)
(4) ステアリン酸イヌリン 0.5
(5) 12−ヒドロキシステアリン酸 0.5
(6) マイクロクリスタリンワックス 5.0
(7) 重質流動イソパラフィン 30.0
(8) メチルフェニルポリシロキサン 5.0
(9) デカメチルシクロペンタシロキサン 10.0
(10)トリ2−エチルヘキサン酸グリセリル 残量
(C相)
(11)シリル化処理無水ケイ酸 3.0
(12)赤色201号 0.5
(13)黄色4号 0.3
(14)雲母チタン 1.0
(15)天然ビタミンE 0.1
(16)香料 適量
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相及びC相を30℃で加え、ロールミルにて均一に混合分散する。
Example 28 Liquid Rouge (ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 0.5
(2) Meadowfoam Estride (* 2) 0.9
(3) Liquid paraffin (* 3) 8.0
(Phase B)
(4) Inulin stearate 0.5
(5) 12-Hydroxystearic acid 0.5
(6) Microcrystalline wax 5.0
(7) Heavy liquid isoparaffin 30.0
(8) Methylphenylpolysiloxane 5.0
(9) Decamethylcyclopentasiloxane 10.0
(10) Remaining amount of glyceryl tri2-ethylhexanoate (Phase C)
(11) Cyrilization treatment Silicic anhydride 3.0
(12) Red No. 201 0.5
(13) Yellow No. 4 0.3
(14) Mica titanium 1.0
(15) Natural Vitamin E 0.1
(16) Appropriate amount of fragrance (manufacturing method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. The A phase and the C phase are added to the B phase at 30 ° C., and the mixture is uniformly mixed and dispersed by a roll mill.
実施例29 リップエッセンス
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 1.0
(2) メドウフォームエストリド(*2) 0.5
(3) スクワラン(*12) 10.0
(B相)
(4) パルミチン酸デキストリン 12.0
(5) パラメトキシケイ皮酸2−エチルヘキシル 5.0
(6) トリメチルペンタフェニルトリシロキサン 25.0
(7) ポリエチレンワックス 5.0
(8) ポリブテン 5.0
(9) 2−エチルヘキサン酸セチル 残量
(10)リンゴ酸ジイソステアリル 30.0
(11)N−ラウロイル−グルタミン酸ジ(フィトステリル・ベヘニル・オクチルドデシ
ル) 5.0
(12)メチルパラベン 0.1
(13)ミツロウ 0.5
(14)精製オリーブ油 0.1
(15)精製ホホバ油 0.1
(16)香料 適量
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相を30℃で加え、ロールミルにて均一に混合分散する。
Example 29 Lip Essence (ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 1.0
(2) Meadowfoam Estride (* 2) 0.5
(3) Squalene (* 12) 10.0
(Phase B)
(4) Dextrin palmitate 12.0
(5) 2-Ethylhexyl paramethoxycinnamate 5.0
(6) Trimethylpentaphenyltrisiloxane 25.0
(7) Polyethylene wax 5.0
(8) Polybutene 5.0
(9) Remaining amount of cetyl 2-ethylhexanoate (10) Diisostearyl malate 30.0
(11) Di-lauroyl-glutamic acid (phytosteryl behenyl octyldodecyl) 5.0
(12) Methylparaben 0.1
(13) Beeswax 0.5
(14) Refined olive oil 0.1
(15) Refined jojoba oil 0.1
(16) Appropriate amount of fragrance (manufacturing method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. Phase A is added to phase B at 30 ° C., and the mixture is uniformly mixed and dispersed on a roll mill.
実施例30 口紅オーバーコート
(成分名) 重量(%)
(A相)
(1) セラミド3(*19) 0.5
(2) メドウフォームエストリド(*2) 0.5
(3) 流動パラフィン(*3) 5.0
(B相)
(4) ポリステアリン酸スクロース 1.0
(5) トリメチルペンタフェニルトリシロキサン 25.0
(6) メチルフェニルポリシロキサン 25.0
(7) ジメチルポリシロキサン 3.0
(8) トリメチルシロキシケイ酸 5.0
(9) デカメチルシクロペンタシロキサン 残量
(10)リンゴ酸ジイソステアリル 10.0
(C相)
(11)シリル化処理無水ケイ酸 8.0
(12)香料 適量
*19:Ceramide III(エボニック製)
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相及びC相を30℃で加え、ロールミルにて均一に混合分散する。
Example 30 Lipstick overcoat (ingredient name) Weight (%)
(Phase A)
(1) Ceramide 3 (* 19) 0.5
(2) Meadowfoam Estride (* 2) 0.5
(3) Liquid paraffin (* 3) 5.0
(Phase B)
(4) Sucrose polystearate 1.0
(5) Trimethylpentaphenyltrisiloxane 25.0
(6) Methylphenylpolysiloxane 25.0
(7) Dimethylpolysiloxane 3.0
(8) Trimethylsiloxysilicic acid 5.0
(9) Remaining amount of decamethylcyclopentasiloxane (10) Diisostearyl malate 10.0
(C phase)
(11) Cyrilization treatment Silicic anhydride 8.0
(12) Appropriate amount of fragrance * 19: Ceramide III (made by Evonik)
(Production method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. The A phase and the C phase are added to the B phase at 30 ° C., and the mixture is uniformly mixed and dispersed by a roll mill.
実施例31 ペースト状油性ファンデーション
(成分名) 重量(%)
(A相)
(1) セラミド6(*20) 0.2
(2) メドウフォームエストリド(*2) 0.1
(3) 水添ポリイソブテン(*11) 3.0
(4) イソステアリン酸イソステアリル(*21) 2.0
(B相)
(5) 水添ポリイソブテン 40.0
(6) 流動パラフィン 残量
(7) ミリスチン酸デキストリンエステル 5.0
(C相)
(8) タルク 5.0
(9) カオリン 5.0
(10)酸化チタン 4.0
(11)ベンガラ 1.0
(12)黄酸化鉄 4.0
(13)黒酸化鉄 0.2
(14)シリル化処理無水ケイ酸 5.0
(15)リンゴ酸ジイソステアリル 10.0
(16)香料 適量
*20:Ceramide VI(エボニック製)
*21:クロダモル ISIS−LQ−(JP)(クローダジャパン製)
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相及びC相を30℃で加え、ロールミルにて均一に混合分散する。
Example 31 Paste-like oily foundation (ingredient name) Weight (%)
(Phase A)
(1) Ceramide 6 (* 20) 0.2
(2) Meadowfoam Estride (* 2) 0.1
(3) Hydrogenated polyisobutene (* 11) 3.0
(4) Isostearyl isostearate (* 21) 2.0
(Phase B)
(5) Hydrogenated polyisobutene 40.0
(6) Remaining amount of liquid paraffin (7) Myristic acid dextrin ester 5.0
(C phase)
(8) Talc 5.0
(9) Kaolin 5.0
(10) Titanium oxide 4.0
(11) Bengala 1.0
(12) Iron yellow oxide 4.0
(13) Black iron oxide 0.2
(14) Cyrilization treatment Silicic anhydride 5.0
(15) Diisostearyl malate 10.0
(16) Appropriate amount of fragrance * 20: Ceramide VI (made by Evonik)
* 21: Kurodamol ISIS-LQ- (JP) (manufactured by Croda Japan)
(Production method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. The A phase and the C phase are added to the B phase at 30 ° C., and the mixture is uniformly mixed and dispersed by a roll mill.
実施例32 油性アイグロス
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 0.3
(2) メドウフォームエストリド(*2) 0.4
(3) 流動パラフィン(*3) 7.0
(B相)
(4) 水添ポリイソブテン 30.0
(5) 流動パラフィン 残量
(6) パルミチン酸デキストリン 5.0
(7) パラメトキシケイ皮酸2−エチルヘキシル 1.0
(8) 天然ビタミンE 0.01
(C相)
(9) 赤色202号 0.004
(10)グンジョウ 0.016
(11)酸化チタン 5.0
(12)シリル化処理無水ケイ酸 5.0
(13)トリイソステアリン酸グリセリル 20.0
(14)香料 適量
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相及びC相を30℃で加え、ロールミルにて均一に混合分散する。
Example 32 Oil-based eye gloss
(Ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 0.3
(2) Meadowfoam Estride (* 2) 0.4
(3) Liquid paraffin (* 3) 7.0
(Phase B)
(4) Hydrogenated polyisobutene 30.0
(5) Remaining amount of liquid paraffin (6) Dextrin palmitate 5.0
(7) 2-ethylhexyl paramethoxycinnamate 1.0
(8) Natural Vitamin E 0.01
(C phase)
(9) Red No. 202 0.004
(10) Gunjo 0.016
(11) Titanium oxide 5.0
(12) Cyrilization treatment Silicic anhydride 5.0
(13) Glyceryl triisostearate 20.0
(14) Appropriate amount of fragrance (manufacturing method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. The A phase and the C phase are added to the B phase at 30 ° C., and the mixture is uniformly mixed and dispersed by a roll mill.
実施例33 ペースト状油性ヘヤーワックス
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 0.2
(2) メドウフォームエストリド(*2) 0.1
(3) 流動パラフィン(*3) 2.0
(B相)
(4) ビーズワックス 2.0
(5) 水添ポリイソブテン 10.0
(6) フェニルトリメチコン 5.0
(7) 流動パラフィン 残量
(8) マカデミアナッツ油脂肪酸コレステリル 10.0
(9) ロジン酸ペンタエリスリット 2.0
(10)パルミチン酸デキストリン 3.0
(11)ジメチルポリシロキサン 1CS 0.5
(C相)
(12)黒酸化鉄 2.0
(13)シリル化処理無水ケイ酸 2.0
(14)トリイソステアリン酸グリセリル 20.0
(15)香料 適量
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相及びC相を30℃で加え、ロールミルにて均一に混合分散する。
Example 33 Paste-like oily hair wax
(Ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 0.2
(2) Meadowfoam Estride (* 2) 0.1
(3) Liquid paraffin (* 3) 2.0
(Phase B)
(4) Bead wax 2.0
(5) Hydrogenated polyisobutene 10.0
(6) Phenyltrimethicone 5.0
(7) Remaining amount of liquid paraffin (8) Macademia nut oil fatty acid cholesteryl 10.0
(9) Pentaerythritol rosinate 2.0
(10) Dextrin palmitate 3.0
(11) Dimethylpolysiloxane 1CS 0.5
(C phase)
(12) Black iron oxide 2.0
(13) Cyrilization treatment Silicic anhydride 2.0
(14) Glyceryl triisostearate 20.0
(15) Appropriate amount of fragrance (manufacturing method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. The A phase and the C phase are added to the B phase at 30 ° C., and the mixture is uniformly mixed and dispersed by a roll mill.
実施例34 ヘヤーオイル
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 2.0
(2) メドウフォームエストリド(*2) 1.0
(3) 流動パラフィン(*3) 29.8
(4) コレステロール(*22) 0.2
(B相)
(5) 流動パラフィン 残量
(6) オリーブ油 2.1
(7) オクチルドデカノール 0.8
(8) オキシベンゾン−3 0.05
(9) メチルパラベン 0.05
(10)香料 適量
(11)青色403号 0.0003
*22:海麗マリンコレステロール(日本水産製)
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相を30℃で加え、ディスパーミキサーにて均一に混合分散する。
Example 34 Hair oil
(Ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 2.0
(2) Meadowfoam Estride (* 2) 1.0
(3) Liquid paraffin (* 3) 29.8
(4) Cholesterol (* 22) 0.2
(Phase B)
(5) Remaining amount of liquid paraffin (6) Olive oil 2.1
(7) Octyldodecanol 0.8
(8) Oxybenzone-3 0.05
(9) Methylparaben 0.05
(10) Appropriate amount of fragrance (11) Blue No. 403 0.0003
* 22: Kairei Marine Cholesterol (manufactured by Nippon Suisan Kaisha)
(Production method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. Phase A is added to phase B at 30 ° C., and the mixture is uniformly mixed and dispersed with a disperser mixer.
実施例35 オイル美容液
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 0.5
(2) セラミド3(*15) 0.5
(3) セラミド6(*16) 0.5
(4) メドウフォームエストリド(*2) 2.0
(5) スクワラン(*12) 20.0
(B相)
(6) イソステアリン酸フィトステリル 5.0
(7) スクワラン 13.0
(8) トリパルミチン酸グリセリル 1.5
(9) トリ2−ヘプチルウンデカン酸グリセリル 2.9
(10)ステアリン酸 0.5
(11)サラシミツロウ 4.0
(12)ホホバ油 1.0
(13)2−エチルヘキサン酸セチル 28.0
(14)メドウフォーム油 1.0
(15)デカメチルシクロペンタシロキサン 5.0
(16)テトラ2−エチルヘキサン酸ペンタエリトリット 14.0
(17)d−δ−トコフェロール 0.6
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相を30℃で加え、ディスパーミキサーにて均一に混合分散する。
Example 35 Oil serum
(Ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 0.5
(2) Ceramide 3 (* 15) 0.5
(3) Ceramide 6 (* 16) 0.5
(4) Meadowfoam Estride (* 2) 2.0
(5) Squalene (* 12) 20.0
(Phase B)
(6) Phytosteryl isostearate 5.0
(7) Squalene 13.0
(8) Glyceryl tripalmitin 1.5
(9) Glyceryl tri2-heptylundecanoate 2.9
(10) Stearic acid 0.5
(11) Sarashi Beeswax 4.0
(12) Jojoba oil 1.0
(13) Cetyl 2-ethylhexanoate 28.0
(14) Meadowfoam oil 1.0
(15) Decamethylcyclopentasiloxane 5.0
(16) Pentaerythrit tetra2-ethylhexanoate 14.0
(17) d-δ-tocopherol 0.6
(Production method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. Phase A is added to phase B at 30 ° C., and the mixture is uniformly mixed and dispersed with a disperser mixer.
実施例36 ハンドオイル
(成分名) 重量(%)
(A相)
(1) セラミド2(*1) 1.0
(2) メドウフォームエストリド(*2) 1.0
(3) ジメチコン(*23) 20.0
(B相)
(4) シクロペンタシロキサン 20.0
(5) イソステアリン酸イソステアリル 残量
(6) イソノナン酸イソトリデシル 50.0
(7) ビタミンE 0.1
(8) マカデミアナッツ油 1.0
(9) ホホバ油 2.0
(10)シア脂 3.0
(11)香料 適量
*23:シリコーンSH200オイル 30CS(東レ・ダウコーニング・シリコーン製)
(製造方法)
1.A相を95℃にて均一に加熱溶解し、30℃まで冷却する。
2.B相を90℃にて均一に加熱溶解し、30℃まで冷却する。
3.B相にA相を30℃で加え、ホモミキサーにて均一に混合分散する。
Example 36 Hand oil
(Ingredient name) Weight (%)
(Phase A)
(1) Ceramide 2 (* 1) 1.0
(2) Meadowfoam Estride (* 2) 1.0
(3) Dimethicone (* 23) 20.0
(Phase B)
(4) Cyclopentasiloxane 20.0
(5) Remaining amount of isostearyl isostearate (6) Isotridecyl isononanoate 50.0
(7) Vitamin E 0.1
(8) Macademia nut oil 1.0
(9) Jojoba oil 2.0
(10) Shea fat 3.0
(11) Appropriate amount of fragrance * 23: Silicone SH200 oil 30CS (manufactured by Toray Dow Corning Silicone)
(Production method)
1. 1. Phase A is uniformly heated and dissolved at 95 ° C. and cooled to 30 ° C.
2. Phase B is uniformly heated and dissolved at 90 ° C. and cooled to 30 ° C.
3. 3. Phase A is added to phase B at 30 ° C., and the mixture is uniformly mixed and dispersed with a homomixer.
実施例27〜36は、40℃、6ヶ月間の経時観察でセラミドの結晶化が見られなかった。
In Examples 27 to 36, ceramide crystallization was not observed in the time-lapse observation at 40 ° C. for 6 months.
Claims (2)
(A)光学活性体であるセラミド
(B)メドウフォームエストリド
(C)メドウフォームエストリドを除く25℃で液状である油剤
を含有し、成分(A)の含有量が20.0重量%以下、且つ成分(B)の含有量が成分(A)の含有量の0.2倍〜2.0倍であり、成分(C)の油剤の50.0重量%以上が非極性油であり、成分(A)〜(C)以外の成分の含有量が0.5重量%以下であるラメラ液晶構造を有することを特徴とする非水ゲル状組成物。 The following components (A) to (C)
(A) Ceramide (B) Meadowfoam estride (C) Meadowfoam estride, which is an optically active substance, contains an oil that is liquid at 25 ° C., and the content of component (A) is 20.0% by weight or less. Moreover, the content of the component (B) is 0.2 to 2.0 times the content of the component (A), and 50.0% by weight or more of the oil agent of the component (C) is a non-polar oil. A non-aqueous gel-like composition having a lamellar liquid crystal structure in which the content of components other than the components (A) to (C) is 0.5% by weight or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017091331A JP6908264B2 (en) | 2017-05-01 | 2017-05-01 | Ceramide-containing non-aqueous gel composition and cosmetics containing it |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017091331A JP6908264B2 (en) | 2017-05-01 | 2017-05-01 | Ceramide-containing non-aqueous gel composition and cosmetics containing it |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018188383A JP2018188383A (en) | 2018-11-29 |
JP6908264B2 true JP6908264B2 (en) | 2021-07-21 |
Family
ID=64479395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017091331A Active JP6908264B2 (en) | 2017-05-01 | 2017-05-01 | Ceramide-containing non-aqueous gel composition and cosmetics containing it |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6908264B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102653968B1 (en) * | 2021-08-17 | 2024-04-03 | 코스맥스 주식회사 | Method for manufacturing cosmetic composition with improved stability comprising high content of ceramide |
WO2023120228A1 (en) * | 2021-12-24 | 2023-06-29 | 株式会社 資生堂 | Oil-based cosmetic |
CN115844763A (en) * | 2022-10-10 | 2023-03-28 | 广州市小谭科技有限公司 | Bionic barrier repair emulsion and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008231061A (en) * | 2007-03-22 | 2008-10-02 | Noevir Co Ltd | Cosmetic addition composition, cosmetic and their manufacturing methods |
JP6469426B2 (en) * | 2014-12-02 | 2019-02-13 | 日本メナード化粧品株式会社 | Emulsified cosmetics |
-
2017
- 2017-05-01 JP JP2017091331A patent/JP6908264B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2018188383A (en) | 2018-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11986546B2 (en) | Dextrin fatty acid ester and cosmetic | |
KR100298924B1 (en) | Submersible type cosmetic composition | |
JP7079827B2 (en) | External skin composition containing an oily moisturizer | |
JP2002145738A (en) | Transfer-resistant cosmetic composition containing nonvolatile silicone compound, nonvolatile hydrocarbon- based oil and inert particle phase | |
JP6833572B2 (en) | Cleaning agent composition | |
JP6908264B2 (en) | Ceramide-containing non-aqueous gel composition and cosmetics containing it | |
JP5053683B2 (en) | Water-in-oil emulsified cosmetic | |
WO2018079568A2 (en) | Gel composition | |
CN113164432A (en) | Oily moisturizer and skin external composition comprising same | |
JP2014101344A (en) | Cosmetic | |
KR20140145124A (en) | Resin composition and cosmetic containing said resin composition | |
JP2016188191A (en) | Oily solid labial cosmetic | |
JP2015199708A (en) | Oily cosmetic | |
JP5960475B2 (en) | Cosmetics | |
JP2023159303A (en) | Oil-in-water type cosmetic, and method for producing the same | |
CN112969443A (en) | Water-in-oil composition | |
JP6109592B2 (en) | Oily cosmetics | |
JP4786399B2 (en) | Non-solid lip cosmetic | |
CN113164433B (en) | Oily moisturizer and external composition for skin containing same | |
WO2020111219A1 (en) | Novel composite body and emulsion composition | |
JP2006257038A (en) | Oil-in-water type makeup cosmetic material | |
JP6824544B1 (en) | Water-in-oil emulsion | |
JP2004339128A (en) | Cosmetic | |
WO2024075548A1 (en) | Gel composition and oil-in-water-type composition | |
JP2021147379A (en) | Water-in-oil emulsion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200402 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210225 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210520 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210608 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210624 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6908264 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |